Most cancer patients can eat cheese safely, and for many it can be a valuable source of protein and calcium during treatment. The real question is more textured than a simple yes or no: which cheeses, how much, and at what stage of treatment or survivorship all matter. The answers shift depending on the type of cancer, the kind of cheese, and whether your immune system is compromised by chemotherapy.
Food Safety Comes First When Your Immune System Is Suppressed
The most immediate concern for cancer patients eating cheese has nothing to do with cancer biology and everything to do with infection. Many chemotherapy regimens lower your white blood cell count, leaving you temporarily vulnerable to foodborne bacteria that a healthy immune system would shrug off. During these periods, oncology teams often recommend what is sometimes called a food safety diet, which restricts unpasteurized dairy, raw or undercooked meat and fish, and unpasteurized eggs, while emphasizing safe food handling and storage practices.1PubMed Central. The neutropenic diet and its impacts on clinical, nutritional, and lifestyle outcomes for people with cancer: a scoping review
In practical terms, this means pasteurized cheeses like cheddar, mozzarella, Swiss, and processed cheese slices are generally fine. What you want to avoid during periods of low immunity are soft cheeses made from unpasteurized (raw) milk, such as certain varieties of Brie, Camembert, blue cheese, and queso fresco, because they can harbor Listeria and other harmful bacteria. Hard, aged cheeses are safer even when made from raw milk, because the aging process and low moisture content make them inhospitable to most pathogens. Still, when your immune defenses are at their lowest point, sticking to clearly pasteurized options is the simplest way to stay safe.
Once your white blood cell counts recover between treatment cycles or after treatment ends, the food safety restrictions relax. The cheese question then becomes less about infection risk and more about what the research says regarding dairy, cheese specifically, and cancer outcomes.
The Prostate Cancer Connection
If there is one area where cheese and cancer research gets uncomfortable, it is prostate cancer. Multiple large reviews of the evidence have found a consistent positive association between dairy intake and prostate cancer risk. A systematic review in the World Journal of Men’s Health concluded that higher dairy product intake has been linked to increased risk of developing prostate cancer, and that this association with both incidence and mortality has been documented across multiple studies.2PubMed Central. Milk Consumption and Prostate Cancer: A Systematic Review
Cheese specifically carries a modest but measurable contribution. A meta-analysis of cohort studies published in the American Journal of Clinical Nutrition found that each additional 50 grams of cheese per day was associated with about a 9 percent higher risk of total prostate cancer.3The American Journal of Clinical Nutrition. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies That is roughly the size of a thick slice or a small wedge. The researchers also flagged calcium itself as a potential driver, since high calcium intake from dairy (but not from supplements or non-dairy sources) tracked with increased risk.
For men who already have prostate cancer, this does not necessarily mean cheese is off limits. The studies largely measure risk of developing cancer in the first place, not whether cheese worsens outcomes in someone already diagnosed. But if your oncologist has discussed dietary factors, this is worth raising, particularly if your daily dairy intake is on the high side.
Colorectal Cancer Tells a Different Story
The prostate cancer data might lead you to assume dairy is bad news across the board, but colorectal cancer research points in the opposite direction. A systematic review and meta-analysis published in Advances in Nutrition found that cheese consumption was associated with roughly a 15 percent lower risk of colorectal cancer overall and a 26 percent lower risk of proximal colon cancer specifically.4PubMed Central. Association Between Dairy Product Consumption and Colorectal Cancer Risk in Adults: A Systematic Review and Meta-Analysis of Epidemiologic Studies The protective effect was strong enough that the researchers described cheese as associated with colorectal cancer prevention.
The calcium in cheese likely plays a role here. Calcium binds to bile acids and free fatty acids in the colon, which can reduce the irritation those substances cause to the intestinal lining. Cheese also delivers casein-derived peptides and, in fermented varieties, live bacteria that may contribute to a healthier gut environment. Whatever the precise mechanism, the contrast with prostate cancer is stark: the same food appears protective in one organ and potentially harmful in another. This is why blanket advice about dairy and cancer rarely holds up.
Breast Cancer and the Fat Content Question
Breast cancer research adds another layer of complexity, and here the fat content of the dairy product matters more than whether it is cheese, milk, or yogurt. A large observational study tracked breast cancer survivors and found that high-fat dairy intake was associated with worse outcomes. Women consuming one or more servings of high-fat dairy per day had about a 49 percent higher breast cancer mortality compared to women eating very little high-fat dairy. The pattern held across different types of high-fat dairy products. Low-fat dairy, by contrast, showed no significant association with recurrence or survival.5PubMed Central. High- and Low-Fat Dairy Intake, Recurrence, and Mortality After Breast Cancer Diagnosis
One hypothesis is that fat-soluble compounds, including estrogens and other hormones naturally present in cow’s milk, concentrate in the fat fraction. Higher-fat cheeses would therefore deliver more of these compounds per serving. This fits with the observation that the link between dairy and breast cancer outcomes seems to track with fat content rather than dairy type.
Interestingly, a more recent Mendelian randomization study using genetic data suggested that cheese intake itself might actually lower breast cancer risk. The analysis estimated that each additional 25 grams per day of genetically predicted cheese intake was associated with an 18 percent reduction in overall breast cancer risk.6Journal of Functional Foods. Cheese intake, probiotics and breast cancer: A Mendelian randomization analysis Mendelian randomization studies use genetic variants as proxies for exposure and can sidestep some of the confounding problems that plague observational research. But they are not clinical trials, and this particular finding needs replication before anyone should treat it as settled. The upshot for breast cancer survivors is that choosing lower-fat cheese varieties is a reasonable precaution, while the question of whether cheese is genuinely protective remains open.
Why Cheese Behaves Differently from Milk
One of the more useful findings for cheese-loving cancer patients is that cheese does not appear to raise insulin-like growth factor 1 (IGF-1) the way liquid milk does. IGF-1 is a growth-promoting hormone, and higher circulating levels have been linked to increased risk of several cancers. A large study in the UK Biobank found that milk protein intake was clearly associated with higher IGF-1 concentrations, but cheese protein showed no such relationship.7PubMed Central. Associations of circulating insulin-like growth factor-I with intake of dietary proteins and other macronutrients A separate study in German adults confirmed this pattern: each additional glass of milk per day was linked to meaningfully higher IGF-1 levels, while cheese intake had no detectable effect on IGF-1 at all.8PubMed. Association of dietary intake of milk and dairy products with blood concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults
The reason is probably the fermentation and aging process. When milk is turned into cheese, the whey (the liquid portion that contains most of the IGF-1-stimulating proteins) is drained off. What remains is mostly casein, fat, and the products of bacterial fermentation. The processing essentially strips out the components of milk most strongly linked to IGF-1 elevation. This does not make cheese cancer-neutral, but it does mean that lumping cheese together with a glass of milk when discussing cancer risk overlooks real biochemical differences.
High-Fat Versus Low-Fat Dairy After a Diagnosis
The fat content distinction matters for survivorship outcomes beyond breast cancer. A study tracking colorectal cancer survivors found that high-fat dairy, including whole milk and cream cheese, was associated with about a 33 percent increase in overall mortality when comparing high consumers with low consumers. Low-fat dairy products, including skim milk and cottage cheese, showed the opposite trend: higher intake was linked to roughly a 26 percent reduction in overall mortality.9PubMed Central. Postdiagnostic dairy products intake and colorectal cancer survival in US males and females Neither high-fat nor low-fat dairy was significantly associated with colorectal-cancer-specific death in that study, suggesting the effect may operate through cardiovascular or metabolic pathways rather than through the cancer itself.
The practical message from the survivorship data is fairly consistent across cancer types: if you are going to eat dairy after a cancer diagnosis, lower-fat options seem to carry fewer risks. That means part-skim mozzarella, reduced-fat cheddar, cottage cheese, and similar products deserve priority over triple-cream Brie or heavily processed cheese spreads. This does not mean a slice of full-fat cheddar is dangerous, but habitual high intake of high-fat dairy products is where the concerning signals appear.
Digestive Trouble During Treatment
Even when cheese is nutritionally appropriate, your body may have other ideas during chemotherapy. Certain chemotherapy drugs damage the lining of the small intestine, which is where the enzyme that digests lactose lives. A study of patients undergoing chemotherapy for colorectal and gastric cancer found that about 45 percent tested positive for lactose intolerance during treatment, and roughly two-thirds of those with lactose intolerance experienced moderate to severe diarrhea.10SciELO / Arquivos de Gastroenterologia. Noninvasive Breath Tests for Diagnosis of SIBO and Lactose Intolerance in Patients on Chemotherapy Treatment for Colorectal and Gastric Cancer If you had no trouble with dairy before starting treatment and suddenly find that cheese causes bloating, cramps, or loose stools, treatment-induced lactose intolerance is a likely explanation.
Aged and hard cheeses tend to be better tolerated because they contain very little residual lactose. Parmesan, aged cheddar, Gruyère, and Swiss are all naturally low-lactose options. Soft, fresh cheeses like ricotta, cream cheese, and cottage cheese retain more lactose and are more likely to cause trouble. Lactase supplements taken before eating can also help bridge the gap if you want to keep dairy in your diet during treatment.
Taste changes are another hurdle. A narrative review of chemotherapy-related taste disturbances found that taste alterations were reported in over 40 percent of cancer patients and contributed strongly to reduced food intake, food aversion, and even malnutrition.11PubMed Central. Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review Some patients find that cheese tastes metallic, overly salty, or just “off” during certain treatment phases. Others find that strongly flavored cheeses are one of the few foods that still taste like something. This variability means experimentation is unavoidable: what works in week one of a chemo cycle may not work in week three.
Fermented Cheese and the Gut Microbiome
Cancer patients receiving immunotherapy have a particular reason to pay attention to fermented foods, cheese included. The gut microbiome influences how well checkpoint-inhibitor drugs work, and emerging evidence suggests that a more diverse microbial community in the gut is associated with better immunotherapy responses. A review in the European Journal of Cancer noted that fermented foods may have a beneficial effect on the gut microbiome and recommended introducing them where possible for cancer patients.12PubMed. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
Not all cheese qualifies as a meaningful source of live bacteria. Highly processed cheese slices and cheese spreads are heated to the point that any live cultures are killed. But traditionally made fermented cheeses with live cultures, including certain aged cheddars, Gouda, some Swiss varieties, and soft-ripened cheeses like genuine Brie and Camembert, can deliver live microbes to the gut. The caveat from the food safety section applies here: if your immune system is suppressed, the infection risk from unpasteurized soft cheeses outweighs any microbiome benefit. Once your counts recover, adding naturally fermented cheeses back into your diet is reasonable and potentially helpful, especially if you are on or heading toward immunotherapy.
Conjugated Linoleic Acid and Other Bioactive Compounds
Cheese, especially from grass-fed cows, contains conjugated linoleic acid (CLA), a naturally occurring fatty acid that has attracted attention for its potential anti-cancer properties. Laboratory research has shown that CLA and its isomers can inhibit the growth of several cancer cell lines, including cervical, liver, and breast cancer cells, and that this effect appears to be dose-dependent. The mechanism involves activation of pathways that trigger programmed cell death in cancer cells.13Arquivos Brasileiros de Medicina Veterinária e Zootecnia. The anticancer activity of milk rich in conjugated linoleic acid
Before you start viewing cheese as a cancer-fighting superfood, though, some perspective: the same research found that whole milk itself did not inhibit cancer cell growth and in some cases appeared to enhance it due to its nutritive value. Only the isolated lipid fraction containing concentrated CLA showed anti-cancer effects. The amount of CLA you get from eating a normal portion of cheese is far less concentrated than what was used in those lab experiments. CLA in cheese is a scientifically interesting component, not a treatment strategy.
When Cheese Is Especially Valuable
Malnutrition is one of the most common and most dangerous complications of cancer treatment. When patients lose weight, their ability to tolerate chemotherapy drops, treatment delays become more likely, and outcomes worsen. Cheese is calorie-dense, protein-rich, and does not require cooking, which makes it useful for patients struggling with fatigue, nausea, or limited kitchen energy. A small amount of cheese on crackers or melted into scrambled eggs can deliver meaningful nutrition without requiring much appetite.
For patients with mouth sores (oral mucositis), soft cheeses like cottage cheese or ricotta can be easier to eat than most other protein sources. For those dealing with cancer-related cachexia or involuntary weight loss, the caloric density of full-fat cheese becomes an advantage rather than a concern. In these situations, the survivorship data about high-fat dairy and mortality takes a back seat to the more immediate need to maintain body weight and muscle mass through treatment. Your oncology dietitian can help you weigh these competing priorities based on where you are in treatment.
Saturated Fat and Inflammation
One concern that comes up frequently is whether the saturated fat in cheese fuels inflammation, which could theoretically promote cancer progression. A study of breast cancer survivors measured inflammatory markers in the blood and compared them to saturated fat intake. The researchers found no significant associations between saturated fat consumption and circulating levels of inflammatory markers.14PubMed Central. Intakes of saturated and unsaturated fat and circulating levels of inflammatory markers among breast cancer survivors This does not mean saturated fat is harmless, but it does suggest that the inflammation pathway is not the primary mechanism by which high-fat dairy might affect cancer outcomes. The fat-soluble hormone concentration hypothesis discussed earlier in the context of breast cancer may be a better explanation for the patterns seen in observational studies.
The broader point is that cheese’s saturated fat content is a legitimate consideration for heart health and metabolic risk, but the leap from “saturated fat causes inflammation” to “cheese feeds cancer” is not well supported by the evidence as it currently stands. Cancer patients already managing enough anxiety about their diets probably do not need to add that particular worry to the list.
How Different Cheeses Stack Up
Not all cheese is the same product nutritionally, and the differences matter for cancer patients. Here is a rough guide to how common varieties compare on the factors discussed throughout this article:
- Aged hard cheeses (Parmesan, aged cheddar, Gruyère): very low in lactose, safe during immune suppression if pasteurized, high in calcium, and typically contain more CLA than fresh cheeses. A good all-around choice during treatment.
- Part-skim mozzarella: lower in fat than most cheeses, low in lactose, mild flavor that works well when taste is altered, and easy to add to cooked dishes for extra protein.
- Cottage cheese: high in protein relative to calories, low in fat if you choose the low-fat version, but contains more lactose than aged cheeses. Best tolerated between chemo cycles when lactose digestion has recovered.
- Soft-ripened cheeses (Brie, Camembert): potentially good sources of live bacteria for microbiome support, but a food safety risk during immune suppression. Save these for when your blood counts are normal and choose pasteurized versions when available.
- Blue cheese: typically made with mold cultures and sometimes raw milk. Avoid during neutropenic periods. Reintroduce cautiously after treatment.
- Processed cheese: low food safety risk because of heavy processing, but also stripped of any live cultures and often high in sodium. Functional as a calorie and protein source when nothing else appeals, but nutritionally inferior to whole-food cheese.
Cheese During Immunotherapy Versus Chemotherapy
The practical advice for cheese shifts depending on the type of treatment you are receiving. During conventional cytotoxic chemotherapy, the main concerns are food safety (because of neutropenia), lactose intolerance (because of gut lining damage), and taste changes. The evidence supports sticking with pasteurized, aged, lower-lactose varieties during active chemo cycles and being more adventurous between cycles when counts are up.
During immunotherapy, food safety is less of a concern because most checkpoint inhibitors do not cause the same degree of immune suppression as traditional chemo. Gut health becomes the priority instead, given the growing evidence linking microbiome diversity to immunotherapy response. Fermented dairy products, including traditionally made cheeses with live cultures, align with the direction the research is heading, though the evidence is still early-stage. Patients on immunotherapy should discuss dietary strategies with their care team, but adding diverse fermented foods is unlikely to cause harm and may help.